查找临床试验
已按「卵巢癌」检索，对应国际通用词 ovarian cancer
共找到 577 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 23:03，每 5 分钟自动同步Access to Genetic Testing in Underserved Patients With Cancer
United States
年龄 18 Years – 不限
University of Southern California
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
Netherlands
年龄 18 Years – 不限
Maxima Medical Center
Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy
France
年龄 18 Years – 不限
Centre Jean Perrin
Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas
Japan
年龄 20 Years – 不限
Kanazawa University
ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients
United Kingdom
年龄 18 Years – 不限
Pierian Biosciences
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
United States、Japan
年龄 18 Years – 不限
Tanabe Pharma America, Inc.
Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
United States
年龄 18 Years – 不限
Ronald Buckanovich
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
United States、Australia、Belgium、France、Israel 等 10 国
年龄 18 Years – 不限
Regeneron Pharmaceuticals
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
United States
年龄 18 Years – 不限
Ohio State University Comprehensive Cancer Center
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
Italy
年龄 不限 – 不限
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
United States、Australia、Canada、France、Germany 等 12 国
年龄 8 Years – 不限
Fore Biotherapeutics
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
United States
年龄 18 Years – 不限
Memorial Sloan Kettering Cancer Center